The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


SCLP SCANCELL HOLDINGS PLC ORD 0.1P

SCANCELL HLDGS  Currency  GBX 



 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 12-Sep-2014 SCLP Presenting at Upcoming Scientific Conferences RNS -2.54% Down
07:00 04-Sep-2014 SCLP Final Results RNS -5.36% Down
07:00 12-Aug-2014 SCLP Synergy of SCIB1 with checkpoint inhibitors RNS +9.17% Up
07:00 19-Jun-2014 SCLP Director/PDMR Shareholding RNS -0.48% Down
07:00 06-Jun-2014 SCLP DNA ImmunoBody Patent Granted in United States RNS -3.71% Down
07:00 02-Jun-2014 SCLP Update on Phase 1/2 trial of SCIB1 in melanoma RNS -3.52% Down
07:30 15-May-2014 SCLP Presents latest SCIB1 data at ASCO RNS +5.81% Up
08:30 09-May-2014 SCLP Directorate Change RNS -0.25% Down
07:00 01-May-2014 SCLP Dr Sally Adams to Join as Development Director RNS +1.56% Up
07:00 04-Apr-2014 SCLP Scancell to present SCIB1 at AACR RNS +5.90% Up
07:00 21-Mar-2014 SCLP 8mg Higher Dose SCIB1 Study On Track RNS +4.82% Up
07:00 18-Feb-2014 SCLP Publication of Moditope Patent RNS -0.52% Down
07:00 11-Feb-2014 SCLP SCIB1 Granted FDA Orphan Drug Status RNS -2.02% Down
16:43 10-Feb-2014 SCLP Holding(s) in Company RNS +0.73% Up
07:00 06-Jan-2014 SCLP Nottingham Technology Grant RNS -5.31% Down
07:00 16-Dec-2013 SCLP Nottingham Trent University Cancer Protein Study RNS -2.69% Down
07:00 12-Dec-2013 SCLP DNA ImmunoBody Patent Granted in Japan RNS -0.56% Down
07:00 11-Dec-2013 SCLP Director/PDMR Shareholding RNS +2.59% Up
07:00 09-Dec-2013 SCLP New data for SCIB1 in metastatic melanoma RNS +15.51% Up
07:00 09-Dec-2013 SCLP Half Yearly Report RNS +15.51% Up

 Page 1 of 2

| 1 | 2 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


SCANCELL HLDGS share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds